Al Lawati Adil, Khamis Faryal, Al Habsi Samiha, Al Dalhami Khazina
Acute Medicine, Department of Medicine, Royal Hospital, Muscat, Oman.
Adult Infectious Diseases, Department of Medicine, Royal Hospital, Muscat, Oman.
Oman Med J. 2021 Mar 24;36(2):e236. doi: 10.5001/omj.2021.110. eCollection 2021 Mar.
Healthcare workers (HCWs), especially those working on the front line, are considered to be at high risk of nosocomial acquisition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Little is known about the effectiveness of the recommended protective methods as few reports have described spread of the disease in hospital settings among this high-risk population. We describe the hospital-based transmission of SARS-CoV-2 related to non-invasive ventilation (NIV) in one of the main tertiary care hospitals in Oman.
All exposed patients and HCWs from Royal Hospital were screened, quarantined, and underwent telephone interviews to stratify their risk factors, clinical symptoms, and exposure risk assessment.
A total of 46 HCWs and patients tested positive for SARS-CoV-2 after exposure to an index case who received 48 hours of NIV before diagnosing COVID-19 infection. Over half of the exposed (56.5%; n = 26) were nurses, 26.1% (n = 12) were patients, and 15.2% (n = 7) were doctors. None of the HCWs required hospitalization. Sore throat, fever, and myalgia were the most common symptoms.
NIV poses a significant risk for SARS-CoV-2 transmission within hospital settings if appropriate infection control measures are not taken.
医护人员(HCWs),尤其是一线工作人员,被认为医院获得性感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即导致2019冠状病毒病(COVID-19)的病毒)的风险很高。对于推荐的防护方法的有效性知之甚少,因为很少有报告描述该疾病在这一高风险人群的医院环境中的传播情况。我们描述了阿曼一家主要三级医疗医院中与无创通气(NIV)相关的SARS-CoV-2的医院内传播情况。
对皇家医院所有暴露的患者和医护人员进行筛查、隔离,并进行电话访谈,以分层分析他们的风险因素、临床症状和暴露风险评估。
在接触一名确诊COVID-19感染前接受了48小时无创通气的索引病例后,共有46名医护人员和患者的SARS-CoV-2检测呈阳性。超过一半的暴露者(56.5%;n = 26)是护士,26.1%(n = 12)是患者,15.2%(n = 7)是医生。没有医护人员需要住院治疗。喉咙痛、发烧和肌痛是最常见的症状。
如果不采取适当的感染控制措施,无创通气在医院环境中对SARS-CoV-2传播构成重大风险。